|1.||Song, J H: 1 article (01/2009)|
|2.||Choi, H J: 1 article (01/2009)|
|3.||Kwon, D H: 1 article (01/2009)|
|4.||Lim, C H: 1 article (01/2009)|
|5.||Baek, S H: 1 article (01/2009)|
|1.||Human Influenza (Influenza)
01/01/2009 - "Antiviral assay using cytopathic effect (CPE) reduction method showed that raoulic acid possessed strong antiviral activity against human rhinovirus 2 (HRV2) with a 50% inhibition concentration (IC(50)) value of less than 0.1mug/ml, human rhinovirus 3 (HRV3) with a IC(50) value of 0.19 microg/ml, coxsackie B3 (CB3) virus with IC(50) values of 0.33 microg/ml, coxsackie B4 (CB4) virus with IC(50) values of 0.40 microg/ml, and enterovirus 71 (EV71) virus with IC(50) values of less than 0.1 microg/ml. However, the compound did not possess antiviral activity against influenza A (Flu A/PR, Flu A/WS, H1N1) and B viruses at four concentrations ranging from 0.1 to 100 microg/ml."